Category
Pressure is building for pharmaceutical companies to price drugs more fairly. But what does equitable pricing look like in practice?
Pressure is building for pharmaceutical companies to price drugs more fairly. But what does equitable pricing look like in practice?
For companies that set out to solve debilitating problems, social benefits aren’t just an added value: they’re the only reason for being in business. One has a new way to help the millions of people worldwide who suffer from obstructive sleep apnea.
Some companies are cutting corners in the rush to commit to net zero by 2050. One example illustrates a better way to go about it.
By definition, conglomerates are made up of many different entities, with their own management and goals. Is the structure an obstacle to environmental and social progress?
With the promise of widespread clean hydrogen fuel still to be realized, what can a more traditional company do to get us there?
With medical waste systems already under strain, the COVID-19 pandemic took things to a new level. How will corporations, and governments, respond?
After identifying issues of concern for an otherwise exemplary company, shareholder engagement—and, in some cases, filing shareholder proposals—can be a crucial strategy to advance ESG goals, as we illustrate with US Bank.
How should investors focused on emissions and climate change approach a company with a significant fossil fuel-related business segment, but an even greater focus on energy efficiency and renewables?
How today’s leading ESG companies align corporate philanthropy with business objectives, to the benefit of social goals and the financial bottom line.
For investors concerned about climate resilience, niche companies like Simpson Manufacturing may be just as important as more obvious “green economy” players.
Copyright © Prentiss Smith & Company 2023
Lead homepage photo © Images of Vermont
